News & Events | Leica Biosystems

Updates about Leica Biosystems.

Leica Biosystems and Navinci Partner to Accelerate Cancer Research Through First-Ever Fully Automated In Situ Proximity Ligation Assays

Published: 11 June 2024

Leica Biosystems, a global leader in anatomic pathology, and Navinci, a leader in developing innovative solutions for studying protein interactions, announce a strategic collaboration to drive innovation in cancer patient care. This partnership enables automated in situ proximity ligation assays on…

Leica Biosystems Strengthens Portfolio with FDA Clearance of Class II Mismatch Repair (MMR) Panel

Published: 3 April 2023

The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers…

Paige and Leica Biosystems Announce Expanded Partnership to Enhance Use of Image Management and Artificial Intelligence Technology in Global Digital Pathology Workflows

Published: 13 March 2023

Leica Biosystems to adopt Paige's image management and AI system for sale with Leica Biosystems Aperio digital pathology slide scanners NEW YORK and VISTA, Calif. – March 13, 2023 – Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and Leica Biosystems,…